Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Controlled Trial ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(12)61227-6 ◽

2012 ◽

Vol 380 (9851) ◽

pp. 1387-1395 ◽

Cited By ~ 637

Author(s):

Scott D Solomon ◽

Michael Zile ◽

Burkert Pieske ◽

Adriaan Voors ◽

Amil Shah ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793467314 ◽

2012 ◽

Author(s):

Jerome Fleg

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction: A Phase II Randomised-Controlled Trial

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2012.10.006 ◽

2012 ◽

Vol 18 (11) ◽

pp. 883 ◽

Cited By ~ 2

Author(s):

Scott D. Solomon ◽

Michael Zile ◽

Burkert Pieske ◽

Adriaan A. Voors ◽

Amil Shah ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Phase Ii ◽

Controlled Trial ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction—the ILO‐HOPE randomised controlled trial

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14484 ◽

2020 ◽

Author(s):

Cho‐Kai Wu ◽

Jen‐Fang Cheng ◽

Chen‐Yu Huang ◽

Zheng‐Wei Chen ◽

Ssu‐Yuan Chen ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Controlled Trial ◽

Faculty Opinions recommendation of Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739033765.793589943 ◽

2021 ◽

Author(s):

WH Wilson Tang

Keyword(s):

Heart Failure ◽

Iron Deficiency ◽

Acute Heart Failure ◽

Controlled Trial ◽

Ferric Carboxymaltose ◽

Double Blind ◽

Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes

Circulation ◽

10.1161/circulationaha.120.050398 ◽

2020 ◽

Vol 142 (13) ◽

pp. 1246-1248

Author(s):

Sheldon W. Tobe ◽

Stephanie Poon

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Inhibitor Therapy ◽

Angiotensin Receptor Neprilysin Inhibitor

Angiotensin Receptor ◽

Renal Outcomes ◽

Neprilysin Inhibitor ◽

Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial

Vaccine ◽

10.1016/j.vaccine.2019.11.061 ◽

2020 ◽

Vol 38 (6) ◽

pp. 1513-1519 ◽

Cited By ~ 9

Author(s):

Vianney Tricou ◽

Jenny G. Low ◽

Helen M. Oh ◽

Yee-Sin Leo ◽

Shirin Kalimuddin ◽

...

Keyword(s):

Single Dose ◽

Controlled Trial ◽

Phase 2 ◽

Dengue Vaccine ◽

Double Blind ◽

Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696

Circulation Heart Failure ◽

10.1161/circheartfailure.114.001427 ◽

2014 ◽

Vol 7 (6) ◽

pp. 953-959 ◽

Cited By ~ 56

Author(s):

Pardeep S. Jhund ◽

Brian L. Claggett ◽

Adriaan A. Voors ◽

Michael R. Zile ◽

Milton Packer ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Troponin T ◽

High Sensitivity ◽

Angiotensin Receptor ◽

High Sensitivity Troponin ◽

Neprilysin Inhibitor ◽

High Sensitivity Troponin T

Effects of angiotensin-receptor neprilysin inhibitor on exercise capacity, quality of life, and cardiac function in heart failure with preserved ejection fraction

Medicine: Case Reports and Study Protocols ◽

10.1097/md9.0000000000000160 ◽

2021 ◽

Vol 2 (10) ◽

pp. e0160

Author(s):

Hidekatsu Fukuta ◽

Hiromi Hagiwara ◽

Takeshi Kamiya

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Exercise Capacity ◽

Angiotensin Receptor Neprilysin Inhibitor

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)33206-6 ◽

2018 ◽

Vol 71 (11) ◽

pp. A2665 ◽

Cited By ~ 4

Author(s):

Tor Biering-Sorensen ◽

Amil Shah ◽

Brian Claggett ◽

Michael Zile ◽

Burkert Pieske ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Left Ventricular ◽

Myocardial Deformation ◽

Angiotensin Receptor Neprilysin Inhibitor

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽